What type of study is this?

August 18, 2025JAMA Internal Medicine

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act

View Full Paper

Ask AI

Bookmark

Authors

CCChristopher CaiBrigham and Women's Hospital ABAnushka BhaskarBrigham and Women's Hospital AKAaron S. KesselheimBrigham and Women's Hospital

Discussion

Member takes

Implication

Serial cross-sectional study measures cost sharing increases in Medicare Part D plans post-IRA implementation, suggesting implications for affordability.

Key Points

Mean monthly out-of-pocket costs for brand-name drugs rose to $73 in 2025, indicating significant cost burden shifts.
In Medicare Advantage plans, deductibles decreased to $66 in 2024 then rose to $228 in 2025, highlighting fluctuating cost trends.
Observational analysis on Medicare enrollees from 2019 to 2025 examines changes in premiums and deductibles across plan types.
The findings call for additional policies to address rising cost sharing and ensure essential medication affordability.

Cite This Study

Cai et al. (2025) studied this question.

synapsesocial.com/papers/68af4754ad7bf08b1ead3d02 https://doi.org/10.1001/jamainternmed.2025.4003

View Full Paper

Ask AI

Bookmark

Implication

Serial cross-sectional study measures cost sharing increases in Medicare Part D plans post-IRA implementation, suggesting implications for affordability.

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act

Discussion

Member takes

Implication

Key Points

Cite This Study

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider